Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
AMIVANTAMAB 3,520 MG-HYALURONIDASE-LPUJ 44,000 UNIT/22 ML SUBCUT SOLN (NDC 57894-522-01) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 17, 2026 , from http://ppman.hank.ai/transparency/procedure/57894-522-01/by-state?code_type=NDC
“AMIVANTAMAB 3,520 MG-HYALURONIDASE-LPUJ 44,000 UNIT/22 ML SUBCUT SOLN (NDC 57894-522-01) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/57894-522-01/by-state?code_type=NDC. Accessed
October 17, 2026 .
“AMIVANTAMAB 3,520 MG-HYALURONIDASE-LPUJ 44,000 UNIT/22 ML SUBCUT SOLN (NDC 57894-522-01) by State,” HANK Price Transparency ,
accessed October 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/57894-522-01/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
57894-522-01 — Amivantamab 3,520 Mg-hyaluronidase-lpuj 44,000 Unit/22 Ml Subcut Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$33,172
National median
$33,172 – $33,172
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 57894-522-01 (NDC), with interquartile range
State Median p25 p75
MD $33,172 $33,172 $33,172